Generation Bio Co. (GBIO)
NASDAQ: GBIO · Real-Time Price · USD
2.160
-0.050 (-2.26%)
Nov 4, 2024, 4:00 PM EST - Market closed
Generation Bio Co. Employees
Generation Bio Co. had 174 employees as of December 31, 2023. The number of employees increased by 24 or 16.00% compared to the previous year.
Employees
174
Change (1Y)
24
Growth (1Y)
16.00%
Revenue / Employee
$75,713
Profits / Employee
-$910,489
Market Cap
144.16M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 174 | 24 | 16.00% |
| Dec 31, 2022 | 150 | 0 | - |
| Dec 31, 2021 | 150 | 50 | 50.00% |
| Dec 31, 2020 | 100 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| MultiPlan | 2,800 |
| Seres Therapeutics | 233 |
| Puma Biotechnology | 185 |
| Inovio Pharmaceuticals | 122 |
| Aclaris Therapeutics | 91 |
| Leap Therapeutics | 54 |
| Cardiff Oncology | 32 |
| Outlook Therapeutics | 24 |
GBIO News
- 13 days ago - Generation Bio Announces the Presentation of Preclinical Data on ctLNP and iqDNA at the ESGCT 31st Annual Congress - GlobeNewsWire
- 7 weeks ago - Generation Bio to Present at the 2024 Cantor Global Healthcare Conference - GlobeNewsWire
- 3 months ago - Generation Bio to Present at the Canaccord Genuity 44th Annual Growth Conference - GlobeNewsWire
- 5 months ago - Generation Bio to Present at the 2024 TD Cowen Genetic Medicines & RNA Summit - GlobeNewsWire
- 6 months ago - Generation Bio Announces Recent Business Highlights and First Quarter 2024 Financial Results - GlobeNewsWire
- 6 months ago - Generation Bio Announces the Presentation of Preclinical Data on iqDNA and ctLNP Platforms at the ASGCT 27th Annual Meeting - GlobeNewsWire
- 7 months ago - Generation Bio Announces the Acceptance of Five Abstracts and an Invited Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting - GlobeNewsWire
- 7 months ago - Generation Bio to Present at the 23rd Annual Needham Virtual Healthcare Conference - GlobeNewsWire